Li X, Zhuo S, Zhuang T, Cho Y, Wu G, Liu Y, et al. YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis. Nat Commun. 2022;13:3075 pubmed publisher

Ali H, Stavik B, Myklebust C, Andersen E, Dahm A, Iversen N, et al. Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5'-Flanking Region. PLoS ONE. 2016;11:e0152114 pubmed publisher

Ucher A, Ranjit S, Kadungure T, Linehan E, Khair L, Xie E, et al. Mismatch repair proteins and AID activity are required for the dominant negative function of C-terminally deleted AID in class switching. J Immunol. 2014;193:1440-50 pubmed publisher

Tonsing Carter E, Hernandez K, Kim C, Harkless R, Oh A, Bowie K, et al. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association. Breast Cancer Res. 2019;21:82 pubmed publisher

Khair L, Baker R, Linehan E, Schrader C, Stavnezer J. Nbs1 ChIP-Seq Identifies Off-Target DNA Double-Strand Breaks Induced by AID in Activated Splenic B Cells. PLoS Genet. 2015;11:e1005438 pubmed publisher

Khair L, Guikema J, Linehan E, Ucher A, Leus N, Ogilvie C, et al. ATM increases activation-induced cytidine deaminase activity at downstream S regions during class-switch recombination. J Immunol. 2014;192:4887-96 pubmed publisher